UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Treatment of Left Ventricular Thrombus With Direct Oral Anticoagulants: A Retrospective Observational Study

The American journal of medicine, 2020-12, Vol.133 (12), p.1488-1491

2020

Volltextzugriff (PDF)

Deep vein thrombosis: pathogenesis, diagnosis, and medical management

Cardiovascular diagnosis and therapy, 2017-12, Vol.7 (S3), p.S276-S284

2017

Volltextzugriff (PDF)

Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants

American journal of kidney diseases, 2020-09, Vol.76 (3), p.311-320

2020

Volltextzugriff (PDF)

Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus

Annals of palliative medicine, 2021-09, Vol.10 (9), p.9427-9434

2021

Volltextzugriff (PDF)

Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants

American journal of kidney diseases, 2023-03, Vol.81 (3), p.307-317.e1

2023

Volltextzugriff (PDF)

Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study

Age and ageing, 2023-03, Vol.52 (3)

2023

Volltextzugriff (PDF)

Can warfarin be replaced by non-vitamin K anticoagulants in prosthetic valves?

Expert review of cardiovascular therapy, 2022-12, Vol.20 (12), p.905-909

2022

Volltextzugriff (PDF)

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists

European heart journal, 2009-12, Vol.30 (23), p.2897-2907

2009

Volltextzugriff (PDF)

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact

Frontiers in cardiovascular medicine, 2021-11, Vol.8, p.742428-742428

2021

Volltextzugriff (PDF)

Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement

Critical care (London, England), 2019-02, Vol.23 (1), p.62-16, Article 62

2019

Volltextzugriff (PDF)

Efficacy and safety of Apixaban in the treatment of cerebral venous sinus thrombosis: a multi-center study

Frontiers in neurology, 2024-05, Vol.15, p.1404099

2024

Volltextzugriff (PDF)

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

Journal of clinical medicine, 2023-09, Vol.12 (18), p.5955

2023

Volltextzugriff (PDF)

Factors influencing real-life use of direct oral anticoagulants in patients with cerebral sinus and venous thrombosis

Journal of stroke and cerebrovascular diseases, 2023-09, Vol.32 (9), p.107223-107223, Article 107223

2023

Volltextzugriff (PDF)

Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study

The American journal of medicine, 2020-08, Vol.133 (8), p.936-945

2020

Volltextzugriff (PDF)

Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies

Current medical research and opinion, 2017-09, Vol.33 (9), p.1583-1594

2017

Volltextzugriff (PDF)

A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulants vs vitamin K antagonists after transcatheter aortic valve replacement in patients with atrial fibrillation

European journal of clinical pharmacology, 2022-10, Vol.78 (10), p.1589-1600

2022

Volltextzugriff (PDF)

Utility of TTR-INR guided warfarin adjustment protocol to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin

Scientific reports, 2024-05, Vol.14 (1), p.11647-11647, Article 11647

2024

Volltextzugriff (PDF)

Incidence of intracranial bleeding in mild traumatic brain injury patients taking oral anticoagulants: a systematic review and meta-analysis

Journal of neurology, 2024-07, Vol.271 (7), p.3849-3868

2024

Volltextzugriff (PDF)

Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: A case report

Clinical case reports, 2023-12, Vol.11 (12), p.e8333-n/a

2023

Volltextzugriff (PDF)

Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

BMC cardiovascular disorders, 2021-08, Vol.21 (1), p.384-384, Article 384

2021

Volltextzugriff (PDF)

Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada

Journal of thrombosis and thrombolysis, 2018-10, Vol.46 (3), p.310-315

2018

Volltextzugriff (PDF)

Relationships, Current Issues, Safety and Efficacy of Oral Anticoagulation in Cancer Patients with Atrial Fibrillation

Journal of clinical medicine, 2023-10, Vol.12 (20), p.6559

2023

Volltextzugriff (PDF)

Clinically relevant non-major bleeding with oral anticoagulants: non-major may not be trivial

Blood transfusion = Trasfusione del sangue, 2018-07, Vol.16 (4), p.387-391

2018

Volltextzugriff (PDF)

Development and validation of a mobile application based on a machine learning model to aid in predicting dosage of vitamin K antagonists among Indian patients post mechanical heart valve replacement

Indian heart journal, 2022-11, Vol.74 (6), p.469-473

2022

Volltextzugriff (PDF)

Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study

Kardiologia polska, 2018-01, Vol.76 (5), p.889-898

2018

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(102)
Buchkapitel
(9)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(94)
Humans
(65)
Anticoagulants
(41)
Vitamin K Antagonists
(40)
Cardiovascular System & Cardiology
(39)
Vka
(39)
Female
(38)
Atrial Fibrillation
(36)
Male
(35)
Administration, Oral
(33)
Vitamin K - Antagonists & Inhibitors
(33)
Aged
(30)
Anticoagulants - Adverse Effects
(30)
Vitamin K
(28)
Cardiac & Cardiovascular Systems
(27)
General & Internal Medicine
(26)
Atrial Fibrillation - Drug Therapy
(25)
Stroke
(25)
Middle Aged
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment of Left Ventricular Thrombus With Direct Oral Anticoagulants: A Retrospective Observational Study

Deep vein thrombosis: pathogenesis, diagnosis, and medical management

Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants

Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus

Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants

Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study

Can warfarin be replaced by non-vitamin K anticoagulants in prosthetic valves?

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact

Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement

Efficacy and safety of Apixaban in the treatment of cerebral venous sinus thrombosis: a multi-center study

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios

Factors influencing real-life use of direct oral anticoagulants in patients with cerebral sinus and venous thrombosis

Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study

Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies

A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulants vs vitamin K antagonists after transcatheter aortic valve replacement in patients with atrial fibrillation

Utility of TTR-INR guided warfarin adjustment protocol to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin

Incidence of intracranial bleeding in mild traumatic brain injury patients taking oral anticoagulants: a systematic review and meta-analysis

Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: A case report

Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada

Relationships, Current Issues, Safety and Efficacy of Oral Anticoagulation in Cancer Patients with Atrial Fibrillation

Clinically relevant non-major bleeding with oral anticoagulants: non-major may not be trivial

Development and validation of a mobile application based on a machine learning model to aid in predicting dosage of vitamin K antagonists among Indian patients post mechanical heart valve replacement

Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study

Suchergebnisse filtern